| pubmed-article:20493424 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0024314 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0432487 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0241910 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0205470 | lld:lifeskim |
| pubmed-article:20493424 | lifeskim:mentions | umls-concept:C0445204 | lld:lifeskim |
| pubmed-article:20493424 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20493424 | pubmed:dateCreated | 2010-5-24 | lld:pubmed |
| pubmed-article:20493424 | pubmed:abstractText | Long term immunosuppression and therapy of acute rejections result in a 20-120-fold increased risk to develop Non Hodgkin lymphoma (NHL). Since immunosuppressive therapy and immunological disorders are major risk factors for the development of NHL in the non-transplant population we aimed to analyze risk factors for PTLD in our cohort of liver transplanted (LT) patients. | lld:pubmed |
| pubmed-article:20493424 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20493424 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20493424 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20493424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20493424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20493424 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20493424 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20493424 | pubmed:issn | 1879-0828 | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:BiesterfeldSt... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:GallePeter... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:OttoGerdG | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:SchuchmannMar... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:ZimmermannTim... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:HeiseMichaelM | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:BarreirosAna... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:SchattenbergJ... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:Hoppe-Lotichi... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:WehlerThomas... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:ZimmermannAnc... | lld:pubmed |
| pubmed-article:20493424 | pubmed:author | pubmed-author:TripkovicVukV | lld:pubmed |
| pubmed-article:20493424 | pubmed:copyrightInfo | Copyright 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:20493424 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20493424 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:20493424 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20493424 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20493424 | pubmed:pagination | 208-15 | lld:pubmed |
| pubmed-article:20493424 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:meshHeading | pubmed-meshheading:20493424... | lld:pubmed |
| pubmed-article:20493424 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20493424 | pubmed:articleTitle | Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD). | lld:pubmed |
| pubmed-article:20493424 | pubmed:affiliation | 1st Department of Medicine, Hepatology, University of Mainz, Germany. | lld:pubmed |
| pubmed-article:20493424 | pubmed:publicationType | Journal Article | lld:pubmed |
